UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Reply: Unblinding in the lecanemab trial in Alzheimer's disease

Hardy, John; Mummery, Catherine; (2023) Reply: Unblinding in the lecanemab trial in Alzheimer's disease. Brain , Article awad201. 10.1093/brain/awad201. Green open access

[thumbnail of awad201.pdf]
Preview
Text
awad201.pdf - Published Version

Download (135kB) | Preview
Type: Article
Title: Reply: Unblinding in the lecanemab trial in Alzheimer's disease
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/brain/awad201
Publisher version: https://doi.org/10.1093/brain/awad201
Language: English
Additional information: © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10176488
Downloads since deposit
456Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item